Dean Lee

21PUBLICATIONS
96CO-AUTHORS
Molecular targetsInnate immunityTumour immunologyHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 14, 2026
Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22.

|Jul 03, 2026
Circumventing Ewing sarcoma tumor microenvironment resistance by IL1RAP CAR-modified TGFβ1-imprinted natural killer cells in combination with IL-15 agonist and anti-GD2 antibody.

|Feb 23, 2026
Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22.

Sumithira Vasu, Nathan Denlinger, No-Joon Song

|Sep 03, 2025
Harmonized immune recovery monitoring after HCT: evidence and practical guidance from the Westhafen Intercontinental Group.

Taymour Hammoudi, Silvia Nucera, Alexandre G Troullioud Lucas

|Jan 10, 2025
High-throughput drug screening identifies SMAC mimetics as enhancers of NK-cell cytotoxicity in chronic myeloid leukemia.

Petra Nygrén, Jonas Bouhlal, Emmi Jokinen

|Sep 12, 2024
Circumventing resistance within the Ewing sarcoma microenvironment by combinatorial innate immunotherapy.

Wen Luo, Hai Hoang, Hongwen Zhu

Pageof 4

Frequent Collaborators

2 joint publications

Jonathan L Bramson

2 joint publications

Zihai Li

2 joint publications

Narendranath Epperla

2 joint publications

Kerry A Rogers